+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Live Cell Encapsulation Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • October 2023
  • Region: Global
  • Expert Market Research
  • ID: 5910828
The global live cell encapsulation market size was valued at USD 258.2 million in 2023, driven by a confluence of technological, clinical, and commercial trends across the globe. The market size is anticipated to grow at a CAGR of 3.6% during the forecast period of 2024-2032 to achieve a value of USD 356.5 million by 2032.

Live Cell Encapsulation: Introduction

Live cell encapsulation is a cutting-edge technique that involves enclosing living cells within a biocompatible, semi-permeable barrier. This barrier effectively shields the encapsulated cells from direct external factors yet permit the exchange of essential nutrients and metabolic waste products. By providing a controlled environment, encapsulation improves cell viability, longevity, and functionality. This technology has garnered attention in biomedicine and biotechnology for its potential applications in tissue engineering, drug delivery, and to transplant cells without the typical concerns of immune rejection.

Key Trends in the Global Live Cell Encapsulation Market

The global live cell encapsulation market was witnessing a transformative phase driven by a confluence of technological, clinical, and commercial trends. A pronounced shift towards regenerative medicine was invigorating the demand for encapsulation technologies, offering unprecedented solutions in drug delivery and cellular therapies. With technological breakthroughs paving the way, advanced biocompatible materials have emerged as game-changers, broadening the horizons of encapsulation applications.

Furthermore, the landscape was brimming with collaborative ventures, as research institutions joined forces with industry behemoths to expedite encapsulation innovations. This synergy was further buoyed by a surge in investments, underscoring the market's robust growth potential. However, intertwined with this optimism were challenges, predominantly regulatory intricacies, and cost implications. Additionally, the geographic epicentre of activities was gradually expanding, with emerging markets showcasing a burgeoning interest in this domain, driven by enhanced healthcare infrastructure and intensified R&D endeavours.

Global Live Cell Encapsulation Market Segmentation

Market Breakup by Manufacturing Techniques

  • Simple Dripping
  • Electrostatic Dripping
  • Coaxial Airflow
  • Liquid-Jet Break-Up
  • Vibrating-Jet Technique
  • Jet Cutting
  • Rotating Disk Atomization

Market Breakup by Polymer Type

  • Alginate
  • HEMA-MMA (HydroxyethylMethacrylate-Methyl Methacrylate)
  • Chitosan
  • Siliceous Encapsulates
  • Cellulose Sulphate
  • PAN-PVC (Poly Acrylonitrile Vinyl Chloride)
  • Others

Market Breakup by Application

  • Drug Delivery
  • Regenerative Medicine
  • Cell Transplantation
  • Probiotics
  • Research

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Live Cell Encapsulation Market Overview

The global live cell encapsulation market represents a dynamic sector at the nexus of biotechnology and medicine. Rooted in the principle of enclosing living cells within a semi-permeable, biocompatible membrane, this technology promises enhanced cell survival, controlled therapeutic delivery, and reduced immune reactions. The market's momentum is primarily fuelled by the burgeoning demand in regenerative medicine and the potential for novel treatment modalities for chronic diseases. With advancements in material science, innovative biocompatible matrices are continually being developed, broadening encapsulation applications. The market is further invigorated by robust investments, both from venture capitals and pharmaceutical giants, eager to harness the potential of cell encapsulation.

Collaborative efforts between academia and industry are also on the rise, seeking to streamline research and commercialization. Yet, the journey isn't without challenges, with regulatory hurdles and cost considerations posing significant barriers. Nonetheless, with its transformative potential, the global live cell encapsulation market is poised for substantial growth, with a keen eye on innovations and patient-centric solutions.

Global Live Cell Encapsulation Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Merck KGaA
  • ViaCyte, Inc.
  • Living Cell Technologies Limited
  • Balchem Inc.
  • Lycored
  • BÜCHI Labortechnik AG
  • Sigilon Therapeutics, Inc.
  • Encapsys, LLC.
  • Evonik Industries AG
  • MIKROCAPS
  • Neurotech Pharmaceuticals
  • BioTime, Inc
  • Gloriana Therapeutics
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Live Cell Encapsulation Market Overview
3.1 Global Live Cell Encapsulation Market Historical Value (2017-2023)
3.2 Global Live Cell Encapsulation Market Forecast Value (2024-2032)
4 Global Live Cell Encapsulation Market Landscape
4.1 Global Live Cell Encapsulation Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Live Cell Encapsulation Product Landscape
4.2.1 Analysis by Manufacturing Techniques
4.2.2 Analysis by Polymer Type
4.2.3 Analysis by Application
5 Global Live Cell Encapsulation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Live Cell Encapsulation Market Segmentation
6.1 Global Live Cell Encapsulation Market by Manufacturing Techniques
6.1.1 Market Overview
6.1.2 Simple Dripping
6.1.3 Electrostatic Dripping
6.1.4 Coaxial Airflow
6.1.5 Liquid-Jet Break-Up
6.1.6 Vibrating-Jet Technique
6.1.7 Jet Cutting
6.1.8 Rotating Disk Atomization
6.2 Global Live Cell Encapsulation Market by Polymer Type
6.2.1 Market Overview
6.2.2 Alginate
6.2.3 HEMA-MMA (HydroxyethylMethacrylate-Methyl Methacrylate)
6.2.4 Chitosan
6.2.5 Siliceous Encapsulates
6.2.6 Cellulose Sulphate
6.2.7 PAN-PVC (Poly Acrylonitrile Vinyl Chloride)
6.2.8 Others
6.3 Global Live Cell Encapsulation Market by Application
6.3.1 Market Overview
6.3.2 Drug Delivery
6.3.3 Regenerative Medicine
6.3.4 Cell Transplantation
6.3.5 Probiotics
6.3.6 Research
6.4 Global Live Cell Encapsulation Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Live Cell Encapsulation Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Live Cell Encapsulation Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Live Cell Encapsulation Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Live Cell Encapsulation Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Live Cell Encapsulation Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Merck KGaA
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 ViaCyte, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Living Cell Technologies Limited
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Balchem Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Lycored
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 BÜCHI Labortechnik AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Sigilon Therapeutics, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Encapsys, LLC.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Evonik Industries AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 MIKROCAPS
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Neurotech Pharmaceuticals
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 BioTime, Inc
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Gloriana Therapeutics
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Live Cell Encapsulation Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Merck KGaA
  • ViaCyte Inc.
  • Living Cell Technologies Limited
  • Balchem Inc.
  • Lycored
  • BÜCHI Labortechnik AG
  • Sigilon Therapeutics Inc.
  • Encapsys LLC.
  • Evonik Industries AG
  • MIKROCAPS
  • Neurotech Pharmaceuticals
  • BioTime Inc
  • Gloriana Therapeutics

Methodology

Loading
LOADING...